Walgreens Spearheads Advancement of Cell and Gene Therapies in Patient Care Expansion

Walgreens announces expansion into cell and gene therapy services in the U.S., aiming to provide specialized care for patients with chronic, rare, or complex conditions. The move includes the launch of a new business unit and the opening of a facility in Pittsburgh dedicated to cell and gene therapies, reflecting the growing importance of specialty pharmacies in the healthcare system. [ad_1] A person rides past a Walgreens truck, owned by the Walgreens Boots Alliance, in Manhattan, New York City, on Nov. 26, 2021. Andrew Kelly | Reuters Walgreens on Thursday said…

Johnson & Johnson tops quarterly profit estimates as medical device sales jump

Johnson & Johnson reports strong first-quarter earnings driven by surging sales in its medical devices business, with total revenue in line with expectations. The company also increases its quarterly dividend and provides updates on acquisitions and legal matters, including ongoing talc-related liabilities. [ad_1] An entry sign to the Johnson & Johnson campus shows their logo in Irvine, California on August 28, 2019. Mark Ralston | AFP | Getty Images Johnson & Johnson on Tuesday reported first-quarter adjusted earnings that topped Wall Street’s expectations as sales in its medical devices business…

Walgreens tops quarterly revenue estimates, but narrows profit outlook in 'challenging' economy

[ad_1] A person rides past a Walgreens truck, owned by the Walgreens Boots Alliance, Inc., in Manhattan, New York City, U.S., November 26, 2021.  Andrew Kelly | Reuters Walgreens on Thursday reported fiscal second-quarter sales that beat Wall Street’s expectations, but lowered the high end of its full-year adjusted earnings outlook in part due to a “challenging” retail environment in the U.S. The company also posted a steep net loss for the quarter as it recorded a hefty nearly $6 billion charge related to the decline in value of its…

Amgen wants in on the booming weight loss drug market — and it's taking a different approach

[ad_1] The Amgen logo is displayed outside Amgen headquarters on May 17, 2023 in Thousand Oaks, California. Mario Tama | Getty Images Amgen is taking a new approach as it tries to stand out in a crowded field of drugmakers racing to develop the next blockbuster weight loss drug. The biotech company is testing an injectable treatment that helps people lose weight differently from the existing injections from Novo Nordisk and Eli Lilly, and other obesity medicines in development. Amgen’s treatment, called MariTide, also appears to help patients keep weight…